Clinical Issues in AIP:

Slides:



Advertisements
Similar presentations
Porphyrias and Errors In Heme Metabolism By: Maria Moreno, Jin-Hee Park, Seo Youn Kim and Newton Wong September 23, 2014 PHM142 Fall 2014 Instructor: Dr.
Advertisements

Pathophysiology of Heme Synthesis Beth A. Bouchard BIOC 212: Biochemistry of Human Disease Spring 2006.
Pathophysiology of Heme Synthesis Beth A. Bouchard BIOC 212: Biochemistry of Human Disease Spring 2005.
Ornithine Transcarbamylase Deficiency Department of Neurosciences Canberra Hospital May 1999.
An unusual case of hyponatraemia Natasha Porcu Southampton General Hospital.
Porphyrin metabolism & porphyrias. What are porphyrins ? Porphyrins Porphyrins are cyclic compounds that bind metal ions (usually Fe2+ or Fe3+) Metaloporphyrin.
Porphyrins and Porphyrias Dr. Zeyad El-Akawi Jreisat, M.D, M.A, Ph.D.
PORPHYRIAS DR AMINA TARIQ BIOCHEMISTRY. Group of disorders either inherited or acquired in the heme synthesis. Congenital erythropoietic porphyria- recessive.
Porphyrias Porphyrias are disorders of haem synthesis. In cutaneous porphyria, unstable intermediates in the haem pathway build up in the skin where they.
How Is Chemotherapy Used to Treat Cancer?
Where Are We on the Path to Elimination of Chronic Hepatitis C?
Bilirubin metabolism and jaundice
A Multidisciplinary Team Approach Challenges and Best Practices in Cushing Disease.
Hepatorenal Syndrome.
Lysosomal Acid Lipase Deficiency: Paving the Path for an Early Diagnosis.
Program Themes. Consulting on Common Concerns in PAH: How Would You Manage These Patients?
Post-autologous Transplant Therapy for Hodgkin Lymphoma
Effective Management of Psoriatic Arthritis: Tailoring Treatments
More Than Meets the Eye: Identifying Who Is at Risk for NASH
Exploring the Spectrum of Excessive Daytime Sleepiness
Hyperkalemia in the Hospital: Collaboration to Improve Transitions of Care.
Glaucoma Progression.
At The Cutting Edge of Developments in the Management of Hyperkalemia
Introduction to Checkpoint Inhibitors
Patient 1: 53-Year-Old Man With CVD Risk Factors
Clinical Review.
Complement and Haemolytic Uraemic Syndrome – ESPN 2008
Case Challenges in Chronic Migraine
Which of the following statements is false about the EEG shown:
Porphyrias.
More Than Treatment.
The Art and Science of Diagnosing Seizures
Chronic Idiopathic Urticaria
Managing Depression in Bipolar I Disorder
Faster-Acting Insulins
Patient Stories: Transitioning to Oral Prostacyclin Pathway Therapy
Best Practices in Metastatic Colorectal Cancer
Porphyrin and Heme Metabolism
62-year-old Man With Unstable Angina
Care of the Treatment-naive Patient With HCV/HIV Coinfection
Porphyrin metabolism & porphyrias
A Roadmap to Diagnosing the Next Patient With Hereditary Angioedema
Translating the Latest and Greatest Advances in PAH Into Clinical Practice.
Multidisciplinary Management of Hyperkalemia:
Nurse View: Practice Pearls in Advanced Pancreatic Adenocarcinoma
Case Study 56-year-old Presents With 1 Year of Worsening Dyspnea
Current and Emerging Strategies for Management of Moderate-to-Severe Atopic Dermatitis.
Multidisciplinary Approaches to Managing Hemophilia
Intermittent Unexplained Abdominal Pain: Is It Porphyria?
Hepatitis C: After the Diagnosis
Managing Age-Related Clinical Issues in Hemophilia
Lysosomal Acid Lipase Deficiency: Paving the Path for an Early Diagnosis.
Recognition and Treatment of Organic Acidemias
Statins, Obesity, and Hyperlipidemia
Lysosomal Acid Lipase Deficiency: Paving the Path for an Early Diagnosis.
Acute Intermittent Porphyria:
Treating Atypical Hemolytic Uremic Syndrome A Case Discussion
A Multidisciplinary Perspective on the Management of Hypoparathyroidism.
Clinical Challenges and Updates in Managing Seizure Clusters
Patient Stories in PAH: Sequential Therapy in a FC II Patient
Assessing the Burden of Hyperkalemia
Contemporary Considerations in Biomarker-Guided Therapy
Prostacyclin Pathway Agents in Action
What Is Acute Intermittent Porphyria? Why AIP Is Often Undiagnosed or Misdiagnosed.
Assessing the Burden of Hyperkalemia
PAH Pathways: What Do the Data Tell Us?”
Championing Evidence-Based Care in Patients With Acute Low Back Pain
The Building Blocks of Homocystinuria and Homocysteinemia Management
Navigating the Journey
A Fresh Perspective on Hypoactive Sexual Desire Disorder
Presentation transcript:

Clinical Issues in AIP:

Hepatic Porphyrias

The Heme Biosynthesis Pathway

AIP Autosomal Dominant Inheritance

AIP Most Common Porphyria, But a Rare Disorder

Case: 24-Year-Old Woman Presents to the ED Classic Clinical Presentation

AIP Classic Clinical Features

AIP Classic Clinical Features (cont)

Take the Patient's History

Physical Examination in a Patient With AIP

Case: 24-Year-Old Woman Presents to the ED (cont) Laboratory Evaluation

You Must Have a High Index of Suspicion

Laboratory Evaluation (cont)

Case: 24-Year-Old Woman Presents to the ED (cont)

A Common Precipitating Factor Hormones

Other Precipitating Factors or Triggers

Initial Management of an Acute Porphyric Attack

Specific Treatment of AIP Hemin

Specific Treatment of AIP Carbohydrate Loading

Variability of Severity of AIP

Consequences of Metabolic Alterations

Long-Term Management of a Complex Disorder With Multisystem Involvement

Preventing Acute Porphyric Attacks

Liver Transplantation in AIP

Emerging Therapies for Correction of Hepatic Heme Biosynthesis

Abbreviations